intelligencia.ai

Intelligencia.ai applies artificial intelligence to drug development. Its platform estimates the risk of clinical trials and explains the factors behind that risk, helping pharmaceutical teams judge which programmes are likely to succeed.

What intelligencia.ai offers

• Probability of success assessments — measures the likelihood of success for drugs across several therapeutic areas.
• Risk driver analysis — pinpoints technical and regulatory factors contributing to risk.
• Competitive landscape review — supports acquisition, licensing and portfolio strategy.
• Trial design signals — detects predictive patterns that can improve clinical trial design.
• Harmonised data — a single source of curated information for consistent risk evaluation.

Who it works with

The customers are pharmaceutical and life sciences organisations, and the site says many large global pharma companies use it.

Key facts

• Team: software engineers, AI practitioners, scientists and drug developers
• Explainability: predictions show which features drive each result